retatrutide mechanism glp-1 gip glucagon triple agonist Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based protocols demand nutrition support alongside prescribing Retatrutide (LY3437943): Mechanism of Action

This comprehensive GLP-1 probiotic supplement combines ingredients traditionally associated with prebiotics, probiotics, and postbiotics in one supplement

Makino H, Nakamura Y, Wada J

Dairy and Other Protein Sources Dairy is a natural pairing of protein and calcium, and research suggests that the combination may support GLP-1 secretion

The evidence is conflicting: Some research shows that nuts increase GLP-1 levels, but another study shows decreased GLP-1 levels after consuming nuts

Food and Drug Administration: FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss Harvard Health Publishing: Understanding New Weight Loss Drugs The New England Journal of Medicine : TripleHormone-Receptor Agonist Retatrutide for Obesity a Phase 2 Trial Yale Medicine: GLP-1 Weight-Loss Pills: What You Need to Know FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss

Studies show that, at the right dosage, oral semaglutide agonists are as effective as injectables